+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID07588672

Study Comparing PL-14 Allergy Blocker and Saline Spray for Adults with Seasonal Allergic Rhinitis to Assess Symptom Relief and Safety

Led by Polyrizon Ltd. · Updated on 2026-09-30

120

Participants Needed

5

Research Sites

11 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the efficacy, safety, and tolerability of PL-14 Allergy Blocker compared to saline spray in adults with Seasonal Allergic Rhinitis SAR, a common condition causing symptoms like sneezing, nasal congestion, and itching triggered by airborne allergens. PL-14 Allergy Blocker is a drug-free intranasal hydrogel designed to form a mechanical barrier on the nasal lining to reduce allergen contact. This prospective, randomized, single-blind study plans to enroll up to 120 participants at multiple sites in the United States. Participants with a history of seasonal allergic rhinitis will first undergo a treatment-free run-in period, then be randomly assigned to self-administer either PL-14 Allergy Blocker or Ayr4 Saline Nasal Mist for up to 30 days. The study focuses on comparing these two devices to assess their effects on nasal allergy symptoms, quality of life, use of rescue medications, and symptom-free days. The active treatment period primarily covers the first 14 days, with continued assessments throughout the 30-day administration. During the study, participants will complete symptom scoring questionnaires, quality of life assessments, and record medication use. Safety will be monitored through adverse event tracking, nasal examinations, and evaluations of local tolerability. Participants will attend multiple visits over approximately 37 days, including screening, treatment, and follow-up phases, allowing researchers to measure the daily reflective Total Nasal Symptom Score and overall impact on allergy symptoms and safety.

CONDITIONS

Brief Title

Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis

Research Team

H

Hilla Ben-Ezra

T

Tidhar Turgeman, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here